GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Additional Paid-In Capital

Glycorex Transplantation AB (NGM:GTAB B) Additional Paid-In Capital : kr128.65 Mil(As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Additional Paid-In Capital?


Glycorex Transplantation AB's quarterly additional paid-in capital stayed the same from Sep. 2024 (kr119.76 Mil) to Dec. 2024 (kr119.76 Mil) but then increased from Dec. 2024 (kr119.76 Mil) to Mar. 2025 (kr128.65 Mil).

Glycorex Transplantation AB's annual additional paid-in capital stayed the same from Dec. 2022 (kr119.76 Mil) to Dec. 2023 (kr119.76 Mil) and stayed the same from Dec. 2023 (kr119.76 Mil) to Dec. 2024 (kr119.76 Mil).

Glycorex Transplantation AB Additional Paid-In Capital Historical Data

The historical data trend for Glycorex Transplantation AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Additional Paid-In Capital Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 119.76 119.76 119.76 119.76 119.76

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.76 119.76 119.76 119.76 128.65

Glycorex Transplantation AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Glycorex Transplantation AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Glycorex Transplantation AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Additional Paid-In Capital
Comparable Companies
OSTO:MVIR OSTO:ANNX OSTO:ATORX OSTO:ALZ XSAT:CURAS OSTO:ISOFOL OSTO:IRLAB A OSTO:KAN OSTO:INIT OSTO:ACTI VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:UCB XBRU:ARGX ONC XKRX:068270 BNTX
Traded in Other Exchanges
O33:Germany
Address
Solvegatan 41, Lund, SWE, 223 70
Website
http://www.glycorex.se
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines